[
  {
    "ts": "2025-11-12T02:55:12+00:00",
    "headline": "Bernstein Assigns Bristol-Myers Squibb Company (BMY) a Hold Rating",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best undervalued stocks to buy under $50. Bristol-Myers Squibb Company (NYSE:BMY) was assigned a Hold rating by Bernstein analyst Courtney Breen on November 3, who maintained the price target at $58. Bristol-Myers Squibb Company (NYSE:BMY) announced strong Q3 results on October 30, with both revenue and EPS […]",
    "url": "https://finance.yahoo.com/news/bernstein-assigns-bristol-myers-squibb-025512415.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6e0a25a4-c486-3726-bac4-589b19895005",
      "content": {
        "id": "6e0a25a4-c486-3726-bac4-589b19895005",
        "contentType": "STORY",
        "title": "Bernstein Assigns Bristol-Myers Squibb Company (BMY) a Hold Rating",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best undervalued stocks to buy under $50. Bristol-Myers Squibb Company (NYSE:BMY) was assigned a Hold rating by Bernstein analyst Courtney Breen on November 3, who maintained the price target at $58. Bristol-Myers Squibb Company (NYSE:BMY) announced strong Q3 results on October 30, with both revenue and EPS […]",
        "pubDate": "2025-11-12T02:55:12Z",
        "displayTime": "2025-11-12T02:55:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-assigns-bristol-myers-squibb-025512415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-assigns-bristol-myers-squibb-025512415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T07:00:00+00:00",
    "headline": "Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership",
    "summary": "Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations FDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec HAMBURG, DE / ACCESS Newswire / November ...",
    "url": "https://finance.yahoo.com/news/evotec-receives-milestone-payment-bristol-070000808.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "c3b333ac-34ed-351d-b9dd-2b6792f0764c",
      "content": {
        "id": "c3b333ac-34ed-351d-b9dd-2b6792f0764c",
        "contentType": "STORY",
        "title": "Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership",
        "description": "",
        "summary": "Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations FDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec HAMBURG, DE / ACCESS Newswire / November ...",
        "pubDate": "2025-11-12T07:00:00Z",
        "displayTime": "2025-11-12T07:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/88388a0adf9baef8921347ec4fb3f334",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "<![CDATA[Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations ...]]>",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFRJtgk9Hu7GPsPx68GSNA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/88388a0adf9baef8921347ec4fb3f334.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pT7LyNms7w5DoFpvsKarFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/88388a0adf9baef8921347ec4fb3f334.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evotec-receives-milestone-payment-bristol-070000808.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evotec-receives-milestone-payment-bristol-070000808.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EVT.DE"
            },
            {
              "symbol": "EVO"
            },
            {
              "symbol": "EVOTF"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T12:00:00+00:00",
    "headline": "Robert A. Winn Excellence in Clinical Trials Award Program Announces 2025 Awardees for the Winn Career Development Award",
    "summary": "The Winn Awards community welcomes 79 new physician-researchers from 23 states NORTHAMPTON, MA / ACCESS Newswire / November 12, 2025 /Originally published by The Robert A. Winn Excellence in Clinical Trials Award Program The Robert A. Winn Excellence ...",
    "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000598.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "7332c13e-59c9-3b64-af9f-2c664222ab8c",
      "content": {
        "id": "7332c13e-59c9-3b64-af9f-2c664222ab8c",
        "contentType": "STORY",
        "title": "Robert A. Winn Excellence in Clinical Trials Award Program Announces 2025 Awardees for the Winn Career Development Award",
        "description": "",
        "summary": "The Winn Awards community welcomes 79 new physician-researchers from 23 states NORTHAMPTON, MA / ACCESS Newswire / November 12, 2025 /Originally published by The Robert A. Winn Excellence in Clinical Trials Award Program The Robert A. Winn Excellence ...",
        "pubDate": "2025-11-12T12:00:00Z",
        "displayTime": "2025-11-12T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/c4f416bd3a0764acebb7b22b52d06222",
          "originalWidth": 700,
          "originalHeight": 622,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mNE2bFLHNiDR1sc6D7SOKQ--~B/aD02MjI7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c4f416bd3a0764acebb7b22b52d06222.cf.webp",
              "width": 700,
              "height": 622,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YamuxvlpMM2elKPae3VKvw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c4f416bd3a0764acebb7b22b52d06222.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robert-winn-excellence-clinical-trials-120000598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:17:46+00:00",
    "headline": "Does Bristol-Myers Squibb’s Rebound Signal Opportunity After Recent Biotech Acquisitions?",
    "summary": "Curious about whether Bristol-Myers Squibb is undervalued or could be a hidden gem? You're not alone, as plenty of investors are asking whether this giant is offering opportunity or risk at today's price. After a long dip early this year, the stock has rebounded, gaining 6.9% in the last week and 10.8% over the past month. However, it remains down 14.2% year to date. Recent headlines have centered on strategic acquisitions in the biotech space and ongoing regulatory developments. Both have...",
    "url": "https://finance.yahoo.com/news/does-bristol-myers-squibb-rebound-141746528.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f25ba2b6-e6a4-37d2-9aea-2d48de6beb36",
      "content": {
        "id": "f25ba2b6-e6a4-37d2-9aea-2d48de6beb36",
        "contentType": "STORY",
        "title": "Does Bristol-Myers Squibb’s Rebound Signal Opportunity After Recent Biotech Acquisitions?",
        "description": "",
        "summary": "Curious about whether Bristol-Myers Squibb is undervalued or could be a hidden gem? You're not alone, as plenty of investors are asking whether this giant is offering opportunity or risk at today's price. After a long dip early this year, the stock has rebounded, gaining 6.9% in the last week and 10.8% over the past month. However, it remains down 14.2% year to date. Recent headlines have centered on strategic acquisitions in the biotech space and ongoing regulatory developments. Both have...",
        "pubDate": "2025-11-12T14:17:46Z",
        "displayTime": "2025-11-12T14:17:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-bristol-myers-squibb-rebound-141746528.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-bristol-myers-squibb-rebound-141746528.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:00:00+00:00",
    "headline": "Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research",
    "summary": "NASHVILLE, Tenn., November 12, 2025--Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, and Bristol Myers Squibb (NYSE: BMY), a leading biopharmaceutical company, today announced an expanded strategic collaboration aimed at accelerating the development of innovative cancer therapies and increasing access to clinical trials for patients across the U.S.",
    "url": "https://finance.yahoo.com/news/sarah-cannon-research-institute-bristol-140000379.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "d796a03e-70f5-3855-b4eb-4e50cc7f0d61",
      "content": {
        "id": "d796a03e-70f5-3855-b4eb-4e50cc7f0d61",
        "contentType": "STORY",
        "title": "Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research",
        "description": "",
        "summary": "NASHVILLE, Tenn., November 12, 2025--Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, and Bristol Myers Squibb (NYSE: BMY), a leading biopharmaceutical company, today announced an expanded strategic collaboration aimed at accelerating the development of innovative cancer therapies and increasing access to clinical trials for patients across the U.S.",
        "pubDate": "2025-11-12T14:00:00Z",
        "displayTime": "2025-11-12T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3915a7eb2c49f6acdae24e43bf4545a0",
          "originalWidth": 1484,
          "originalHeight": 255,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bPZ_43roZDliDJbR_gBuug--~B/aD0yNTU7dz0xNDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3915a7eb2c49f6acdae24e43bf4545a0.cf.webp",
              "width": 1484,
              "height": 255,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jer4koR7OhwHq7xDE5AeHQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3915a7eb2c49f6acdae24e43bf4545a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sarah-cannon-research-institute-bristol-140000379.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sarah-cannon-research-institute-bristol-140000379.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T13:52:45+00:00",
    "headline": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Hopes of Federal Government Reopening",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad",
    "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135245575.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "ef0c0f16-6cd2-3f84-bebb-d763ce1d9659",
      "content": {
        "id": "ef0c0f16-6cd2-3f84-bebb-d763ce1d9659",
        "contentType": "STORY",
        "title": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Hopes of Federal Government Reopening",
        "description": "",
        "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad",
        "pubDate": "2025-11-12T13:52:45Z",
        "displayTime": "2025-11-12T13:52:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135245575.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135245575.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QQQ"
            },
            {
              "symbol": "SPY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "BTC-USD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:50:03+00:00",
    "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finance.yahoo.com/news/why-1-momentum-stock-could-145003665.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "adf89b5a-5e1c-3276-9742-3c81595bfb35",
      "content": {
        "id": "adf89b5a-5e1c-3276-9742-3c81595bfb35",
        "contentType": "STORY",
        "title": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
        "description": "",
        "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
        "pubDate": "2025-11-12T14:50:03Z",
        "displayTime": "2025-11-12T14:50:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wrLAPGGJOM4LTlpriDsibA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KPws6ZxoY5._RUBc.aqcuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-1-momentum-stock-could-145003665.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-1-momentum-stock-could-145003665.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:53:00+00:00",
    "headline": "Psoriatic Arthritis Market Trends and Competitive Analysis, 2025-2035 - Asia-Pacific and Latin America Offer New Growth Opportunities as Demand for Accessible Treatments Rises",
    "summary": "Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading innovations.Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The \"Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering. The growing prevalence of autoimmune diseases, particularly among individu",
    "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e8727f83-3fa8-3e31-a17a-263dc57e15d7",
      "content": {
        "id": "e8727f83-3fa8-3e31-a17a-263dc57e15d7",
        "contentType": "STORY",
        "title": "Psoriatic Arthritis Market Trends and Competitive Analysis, 2025-2035 - Asia-Pacific and Latin America Offer New Growth Opportunities as Demand for Accessible Treatments Rises",
        "description": "",
        "summary": "Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading innovations.Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The \"Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering. The growing prevalence of autoimmune diseases, particularly among individu",
        "pubDate": "2025-11-12T16:53:00Z",
        "displayTime": "2025-11-12T16:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]